Glucosamine and chondroitin supplements will lead bone and joint health supplement sales through 2036 with 32.6% of the product type segment in 2026. Tablets lead the dosage form segment with a 37.4% share. The market was valued at USD 12.3 billion in 2025 and USD 25.36 billion by 2036.